Transdermal Patch for Restless Legs Syndrome
Links shared publicly online about this topic
Neurology News & Articles - MDLinx - Restless Legs Syndrome on #MDlinx
mdlinx.com — “Neurology News & Articles - MDLinx - Restless Legs Syndrome on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 17, 2010 at 12:54 am By:
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, plac... http://bit.ly/aFuBmA #neurology
Medical News: AAN: RLS Patch Safe, Effective Over Long Term - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “TORONTO -- A transdermal patch delivering a dopamine agonist to treat restless legs syndrome was safe and effective over five years, a researcher said here.” View full resource at medpagetoday.com
Most Recently Shared on April 15, 2010 at 3:07 pm By:
AAN: RLS Patch Safe, Effective Over Long Term (CME/CE) TORONTO (MedPage Today) -- A transdermal patch delivering a dopa.. http://dld.bz/atwd
Medical News: APSS: Parkinson's Drug Demonstrates Efficacy for RLS - in Meeting Coverage, APSS from MedPage Today
medpagetoday.com — “SEATTLE -- In a retrospective review of long-term data from two open-label trials, restless legs syndrome (RLS) patients treated with transdermal rotigotine (Neupro) had good symptom relief and no sp” View full resource at medpagetoday.com
Most Recently Shared on June 16, 2009 at 11:33 pm By:
NEUROLOGY• APSS: Parkinson's Drug Demonstrates Efficacy for RLS (CME/CE) http://tinyurl.com/kwefwp
Neupro improves wellbeing impaired by pain related to Restless Legs Syndrome
news-medical.net — “The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS) were presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.” View full resource at news-medical.net
Most Recently Shared on June 18, 2010 at 2:05 pm By:
Neupro improves wellbeing impaired by pain related to Restless Legs Syndrome: The first data to show that Neupro® ... http://bit.ly/9aLXW7
Axxonis Pharma AG Withdraws Its Marketing Authorisation Application For Nenad (lisuride), Europe
medicalnewstoday.com — “The European Medicines Agency has been formally notified by Axxonis Pharma AG of its decision to withdraw its application for a centralised marketing authorisation for the medicine Nenad (lisuride” View full resource at medicalnewstoday.com
Most Recently Shared on December 4, 2009 at 3:28 am By:
Axxonis Pharma AG Withdraws Its Marketing Authorisation Application For Nenad (lisuride), Europe http://ow.ly/166vXx
UCB Receives Complete Response Letter From U.S. FDA Regarding Neupro(E) (Rotigotine)
medicalnewstoday.com — “UCB announced today that the U.S. Food and Drug Administration (FDA) has provided a complete response letter recommending reformulation of Neupro® (Rotigotine Transdermal System) before making” View full resource at medicalnewstoday.com
Most Recently Shared on April 26, 2010 at 4:12 pm By:
UCB Receives Complete Response Letter From U.S. FDA Regarding Neupro(E) (Rotigotine) http://mnt.to/3BL7 #parkinsons
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
medical_tweets
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
Advertisement

